Sorry, you need to enable JavaScript to visit this website.
Title Source Date
Exclusive PBOA Q&A with Pfizer CentreOne GM, JoyL Silva Pharma Bio October, 2019
Tom Wilson discusses better drug manufacturing strategies with Contract Pharma Contract Pharma October, 2019
Pfizer CentreOne's JoyL Silva comments on the evolution of outsourcing in the pharmaceutical industry with Contract Pharma Contract Pharma October, 2019
CDMO market trends and dynamics Pfizer CentreOne April, 2019
The Embedded CDMO Q&A with JoyL Silva Pfizer CentreOne April, 2019
A view of biopharma from Pfizer's Building 41 Outsourced Pharma March, 2019
Is your sterile injectable ready for changes in raw materials? Outsourced Pharma July, 2018
Insight from an expert: a chemist's secrets to efficient API scale-up Pharmaceutical Online June, 2018
Pfizer's drivers for manufacturing: new tech and regulators Outsourced Pharma April, 2018
Is your biologic at risk for protein aggregation? Part 1 — Causes of protein aggregation and the role of stress testing Outsourced Pharma March, 2018
Is your biologic at risk for protein aggregation? Part 2 — How to prevent protein aggregation via considerations for the manufacturing process and container selection Outsourced Pharma March, 2018
Is your biologic at risk for protein aggregation? Part 3 — Drug formulation Outsourced Pharma March, 2018
Fermentation optimization: using comparative statistics to enhance large-scale process productivity Pharmaceutical Online January, 2018
Is selecting a CDMO based on contract price really saving you money in the long run? Bioprocess Online November, 2017
How to use QbD software to improve an existing identification method Outsourced Pharma November, 2017
Is your API ready for scale-up? What to demand from your CDMO BioPharma Dive October, 2017
The value of the embedded-CMO model Drug Development & Delivery June, 2017
Capitalize on your merger/acquisition: 4 tips to consolidate your CMO network BioPharma Dive April, 2017
Overcoming low endotoxin recovery BioPharm International December, 2016
Pfizer on CMOs: $180bn is at stake so being first-to-market is critical in-PharmaTechnologist.com October, 2016
Parenteral advisory: outmoded fill-finish technology BioPharm International September, 2016
Making the correct outsourcing decisions BioProcess International September, 2016
Practical approaches to tech transfer and scale-up of lyophilization processes PharmTech.com May, 2016
Container selection for biologic formulations PharmTech.com April, 2016